GlassScriptPhysician profile
Mark D Fischer
NPI 1801807177
$10,374.14
in general payments reported to CMS, 2019-2025
12 companies · $3,961 in 2025
The $3,961 reported for 2025 was more than what 89% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2021: $11.44 · 2022: $4,521 · 2023: $303 · 2024: $1,378 · 2025: $3,961.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,119 · Food and Beverage: $1,523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,119.28 |
| Food and Beverage | $1,523.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $6,186.23 | 2022-2025 | |
| Foundation Medical, LLC | $2,042.51 | 2023-2025 | |
| Sonex Health, INC. | $1,206.65 | 2022-2024 | Sx-One Microknife |
| Gemini Medical LLC | $376.76 | 2019-2022 | |
| Medartis INC. | $277.02 | 2024 | Aptus |
| Smith+Nephew, INC. | $99.69 | 2023 | Lens 4k |
| Stryker Corporation | $50.56 | 2019 | |
| Orthofix Medical, INC. | $48.24 | 2019-2025 | Physio-Stim |
| Ethicon US, LLC | $30.78 | 2022 | |
| Heron Therapeutics, INC. | $30.00 | 2022 | |
| Integra Lifesciences Corporation | $14.26 | 2019 | |
| Endo Pharmaceuticals INC. | $11.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Fischer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.